Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG).
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorMedical University of Warsaw
About this trial
The aim of this clinical trial is to assess preemptive oral pregabalin administration in the obese patients undergoing laparoscopic sleeve gastrectomy. The main aims of the study are to evaluate postoperative pain treatment and effect on the intraoperative hemodynamical stability.
The participants will be divided into 2 groups: with or without preemptive pregabalin administration.
Eligibility criteria
Qualifiers
Sleeve gastrectomy in patients with BMI > 40 or >35 with comorbidities
Written informed consent
Disqualifiers
Patient's refusal
Known allergies to study medication
Inability to comprehend or participate In pain scoring scale
Inability to use intravenous patient controlled analgesia
Trial design
Treatments tested in this trial
- Pregabalin 150mg
- Placebo
Treatment groups
90 Participants
are divided into 2 treatment groupsLocations
1Szpital Kliniczny Dzieciatka Jezus02-005, WarsawWarsaw, Poland
Sponsors and collaborators
Medical University of Warsaw
Lead sponsor
Source ClinicalTrials.gov